Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device

Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device

The Health Transformation Alliance (HTA), a group of nearly 60 large employers, announced Thursday it is partnering with pediatric behavioral health company Cognoa for its diagnostic device for autism.
HTA is a cooperative of self-insured employers, including Walgreens, CocaCola, Verizon and American Express. Palo Alto, California-based Cognoa, meanwhile, is a developer of AI-based technologies for early diagnosis of children with developmental and behavioral health conditions. Its Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. The product is the first of its sort…

Continue Reading
HTA to Offer Cognoa’s Canvas Dx Diagnostic Device for Autism to Member Organizations

HTA to Offer Cognoa’s Canvas Dx Diagnostic Device for Autism to Member Organizations

What You Should Know:– Health Transformation Alliance (HTA), a cooperative of nearly 60 of America’s largest employers, has partnered with Cognoa, a pediatric behavioral health company, to offer the company’s Canvas Dx diagnostic device for autism to all HTA Member organizations and their employees.– HTA will offer its member organizations – some of the most influential and significant brands in the U.S. – the opportunity to add Canvas Dx to their benefit design.Expanding Horizons By Increasing Accessibility To Child Health ServicesThis partnership comes at an ideal time when the pandemic has exacerbated long-standing gaps in pediatric behavioral and developmental healthcare. As…

Continue Reading